Dr. Kurth is a Director of Research at the French National Institute of Health and Medical Research Institut national de la santé et de la recherche médicale (Inserm), Research Center for Epidemiolgy and Biostatistics (U897) – Team Neuroepidemiology, Bordeaux, France. He is further an Adjunct Professor of Epidemiology at the Harvard T.H. Chan School of Public Health, as well as Lecturer in Medicine at Harvard Medical School..
Tobias Kurth received his M.D. from the University of Tübingen in Germany and a doctorate in epidemiology from the Harvard School of Public Health. He served as a resident in the Department of Neurology at the University Hospital of Essen, Germany, which has a strong focus on migraine headache and stroke.
Dr. Kurth has published >200 articles in indexed journals and is Associate Editor of Cephalalgia and Consulting Clinical Epidemiology Editor at the BMJ. He is involved in teaching and training in France, the United States, and Germany, specifically in clinical epidemiology, neuroepidemiology, and epidemiologic methods.
Tobias Kurth's principal areas of research consist of the following focuses: (i) neuroepidemiology/cardiovascular epidemiology with specific focus on the interrelationships between vascular risk factors, migraine, and cardiovascular disease as well as the prevention and consequences of stroke and Parkinson's disease; (ii) pharmacoepidemiology, specifically the risks and benefits of analgesic use and over-the-counter medications; and (iii) the application of tools to control for confounding in observational studies, particularly the propensity score.